Table 5. Pro-apoptotic inducers of CerS activity.
bFGF, basic fibroblast growth factor; 4-HPR, 4-hydroxy(phenyl)retinamide.
| Inducer | Cell line/experimental system | Reference |
|---|---|---|
| Daunorubicin | P388 lymphocytic leukaemia cells | [60] |
| Doxorubicin | FTC-133 follicular thyroid carcinoma | [97] |
| Camptothecin | FTC-133 follicular thyroid carcinoma | [97] |
| TNF-α | Kym-1 rhabdomyosarcoma cells | [98] |
| Fenretinide (4-HPR) | CHLA-90 neuroblastoma cells | [99] |
| UV light (UV-B) | Human keratinocytes | [100] |
| Vascular endothelial growth factor receptor tyrosine kinase inhibitor SU5416 | Mouse lung | [101] |
| 125I-Deoxyuridine | Bovine aortic endothelial cells | [102] |
| Phorbol ester | CWR22-Rv1 prostate cancer cells | [103] |
| LNCaP prostate cancer cells | [104] | |
| IR | bFGF-treated C57BL6 mice | [105] |
| HeLa cervical carcinoma cells | [71] | |
| IR ± phorbol ester | LNCaP prostate cancer cells | [106] |